The levels of the latter three metabolites in PMC were much lower than those in PLC, suggesting that when plasma concentrations of these three substances decreased significantly, nodules were more likely to be lung metastases than primary lung cancer. This evidence concerns the gene HSPG2 and lung carcinoma.